Three months ago, Donna Witcher, who is legally blind, walked outside her Torresdale home and identified a stop sign.
Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious…read more
October was a big month for video advertising technology company Pixability.
Earlier this month, the company announced that it was…
Respiratory Motion, Inc. Awarded National Group Breakthrough Technologies Purchasing Contract by Premier
Respiratory Motion, Inc. is announcing the award of a group purchasing agreement as a Breakthrough Technology with Premier Inc.,…read more
Neuraly has raised $35 million in support of its research and is preparing for clinical trials expected to begin…read more
When Actavis Plc. acquired Allergan Inc. in March 2015, the company changed its name from Actavis Plc. to Allergan…read more
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it…read more
Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, and The Lake Forest Group, experts in…read more
Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed…read more
Dan Aziz stood outside of pharmacies surveying pregnant women for market research before starting his company, Luna Pharmaceuticals, which…read more